Cargando…
Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists
As part of our effort to discover drugs that target HIV-1 entry, we report the antiviral activity and crystal structures of two novel inhibitors in a complex with a gp120 core. NBD-14204 showed similar antiviral activity against all the clinical isolates tested. The IC(50) values were in the range o...
Autores principales: | Curreli, Francesca, Kwon, Young D., Nicolau, Isabella, Burgos, Giancarla, Altieri, Andrea, Kurkin, Alexander V., Verardi, Raffaello, Kwong, Peter D., Debnath, Asim K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784924/ https://www.ncbi.nlm.nih.gov/pubmed/36555641 http://dx.doi.org/10.3390/ijms232415999 |
Ejemplares similares
-
Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model
por: Stoddart, Cheryl A., et al.
Publicado: (2022) -
Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site
por: Kwon, Young Do, et al.
Publicado: (2014) -
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
por: Curreli, Francesca, et al.
Publicado: (2021) -
NMR spectroscopy of HIV-1 gp120 outer domain
por: Sastry, M, et al.
Publicado: (2012) -
Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120
por: Neurath, A Robert, et al.
Publicado: (2001)